Notable Labs Future Growth
Future criteria checks 0/6
Notable Labs's revenue and earnings are forecast to decline at 162.1% and 36.7% per annum respectively while EPS is expected to decline by 4.4% per annum.
Key information
-36.7%
Earnings growth rate
-4.4%
EPS growth rate
Biotechs earnings growth | 24.4% |
Revenue growth rate | -162.1% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 18 May 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2025 | N/A | -19 | 18,841 | N/A | 2 |
12/31/2024 | N/A | -18 | 11,583 | N/A | 2 |
3/31/2024 | 0 | -9 | -14 | -14 | N/A |
12/31/2023 | 0 | -11 | -14 | -14 | N/A |
9/30/2023 | 0 | -13 | -8 | -8 | N/A |
6/30/2023 | 0 | -18 | -10 | -10 | N/A |
3/31/2023 | 0 | -18 | -10 | -10 | N/A |
12/31/2022 | 0 | -14 | -12 | -12 | N/A |
12/31/2021 | 0 | -16 | -15 | -15 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: NTBL is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: NTBL is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: NTBL is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: NTBL is forecast to have no revenue next year.
High Growth Revenue: NTBL is forecast to have no revenue next year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if NTBL's Return on Equity is forecast to be high in 3 years time